4//SEC Filing
HUMAN GENOME SCIENCES INC 4
Accession 0001225208-11-012073
CIK 0000901219operating
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 10:40 AM ET
Size
8.6 KB
Accession
0001225208-11-012073
Insider Transaction Report
Form 4
Bateson Susan D.
Senior Vice President
Transactions
- Sale
Common Stock
2011-04-20$28.75/sh−24,000$689,998→ 65,270 total - Exercise/Conversion
Common Stock
2011-04-20$0.52/sh+24,000$12,480→ 89,270 total - Exercise/Conversion
Employee Stock Option - Right to Buy
2011-04-20−24,000→ 67,997 totalExercise: $0.52Exp: 2019-03-10→ Common Stock (24,000 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Charles Schwab effective 3/18/11.
- [F2]This transaction was executed in multiple trades at prices ranging from $28.09 to $28.94. The price reported above reflects the weighted average sale price. Upon written request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price is available.
- [F3]One eighth of the options granted vested on September 10, 2009, the six-month anniversary date of the grant, and the remaining options granted vested and continue to vest monthly on a ratable basis for the next 42 months commencing on October 10, 2009.
Documents
Issuer
HUMAN GENOME SCIENCES INC
CIK 0000901219
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000901219
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 10:40 AM ET
- Size
- 8.6 KB